| 599 |
Centers for Disease Control and Prevention |
Html |
en |
FoodCORE - Investigating outbreaks of foodborne disease - CDC Features |
Each year, foodborne diseases cause illness in 1 in 6 Americans (or about 48 million people), resulting in about 128,000 hospitalizations and 3,000 deaths. FoodCORE is a program supported by CDC that helps states detect and respond to multistate foodborne disease outbreaks. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5550 |
Centers for Disease Control and Prevention |
Html |
en |
Paraquat (Paraquat dichloride) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6763 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - South Africa - CDC's HIV/AIDS Care and Treatment Programs |
CDC partners in South Africa with government and parastatal agencies, private institutions, universities and non-governmental organizations to improve the country’s public health foundation, to prevent transmission of HIV, to provide care and treatment for those who are already infected with HIV, and to strengthen laboratory capacity.
|
| viral loads | 0.35268 |
| new infections | 0.336352 |
| high rates | 0.330957 |
| antiretroviral therapy | 0.444837 |
| HSRC Report | 0.373835 |
| universal access | 0.354604 |
| effective treatment | 0.34016 |
| Content source | 0.326183 |
| AIDS deaths | 0.351745 |
| antiretroviral treatment programmes | 0.609803 |
| Strategic Plan | 0.355568 |
| large reductions | 0.364994 |
| immediate benefits | 0.352657 |
| HIV incidence | 0.488112 |
|
| infected individuals | 0.348486 |
| ART roll-out programme | 0.904821 |
| largest ART roll-out | 0.664106 |
| risky behaviour | 0.373627 |
| ART provision | 0.364509 |
| behavioural risk compensation | 0.527921 |
| non-federal site | 0.361427 |
| Treatment portfolio | 0.375802 |
| HIV risk behaviour | 0.682388 |
| South Africa | 0.794593 |
| successful ART roll-out | 0.603728 |
| South African National | 0.578781 |
| CDC South Africa | 0.655589 |
|
CLICK HERE |
| 7089 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Cent. African Republic |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 7222 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012: 12_0157 |
The much-discussed urgency of addressing the obesity epidemic does not obviate the need for well-reasoned actions based on the best available evidence. |
| evidence | 0.641878 |
| suitable evidence | 0.327605 |
| IOM study committee | 0.422351 |
| Evidence quality | 0.33699 |
| evidence review guidance | 0.348434 |
| evidence synthesis methods | 0.361054 |
| available evidence base | 0.384866 |
| environmental obesity prevention | 0.365441 |
| Force obesity prevention | 0.364429 |
| obesity prevention | 0.955015 |
| relevant evidence | 0.348873 |
| external validity | 0.344814 |
| International Obesity Task | 0.385687 |
| evidence gaps | 0.328231 |
| obesity interventions | 0.327992 |
| obesity prevention efforts | 0.38264 |
| decision makers | 0.354144 |
| evidence framework | 0.380745 |
| obesity prevention initiatives | 0.356451 |
| obesity prevention questions | 0.379528 |
| public health context | 0.359184 |
| parallel evidence | 0.332549 |
| credible evidence | 0.34832 |
| practice-based evidence | 0.329934 |
|
| physical activity programs | 0.335444 |
| after-school physical activity | 0.32722 |
| public health contexts | 0.326483 |
| new evidence | 0.388804 |
| evidence report | 0.335917 |
| evidence synthesis | 0.370638 |
| Evidence Gap report | 0.527829 |
| evidence evaluation | 0.330471 |
| obesity prevention strategy | 0.354294 |
| policy changes | 0.33122 |
| evidence sources | 0.359132 |
| Kaiser Permanente | 0.364426 |
| public health | 0.774604 |
| evidence base | 0.511298 |
| policy | 0.3434 |
| useful evidence | 0.339579 |
| Community Health Initiatives | 0.402967 |
| community-based obesity prevention | 0.399821 |
| evidence-based public health | 0.331305 |
| physical activity | 0.596463 |
| best available evidence | 0.381017 |
| obesity epidemic | 0.369077 |
| L.E.A.D. framework | 0.605236 |
| Obesity Task Force | 0.386018 |
|
CLICK HERE |
| 10151 |
Centers for Disease Control and Prevention |
Html |
en |
Mycoplasma pneumoniae: Prevention |
Tips to prevent the spread of Mycoplasma pneumoniae, a common cause of community-acquired pneumonia. |
| future infections | 0.228216 |
| pneumoniae infection | 0.729433 |
| household members | 0.230223 |
| alcohol-based hand rub | 0.357583 |
| upper sleeve | 0.247907 |
| tissue | 0.216191 |
|
| waste basket | 0.249319 |
| Preventive antibiotics | 0.255328 |
| Mycoplasma pneumoniae infection | 0.640605 |
| close contacts | 0.228929 |
| M. pneumoniae infection | 0.720853 |
| M. pneumoniae | 0.905237 |
|
CLICK HERE |
| 10947 |
Centers for Disease Control and Prevention |
Html |
en |
Prostate Cancer Diagnosis |
If your prostate specific antigen (PSA) test or digital rectal exam (DRE) is abnormal, doctors may do more tests to find or diagnose prostate cancer. |
| transrectal ultrasound | 0.223349 |
| Gleason score | 0.216277 |
| magnetic resonance imaging | 0.294659 |
| digital rectal exam | 0.338728 |
| right place | 0.209398 |
| NCI’s Stages | 0.21849 |
| prostate specific antigen | 0.586791 |
| cancer cells | 0.29683 |
|
| visit NCI | 0.226283 |
| main tool | 0.210316 |
| prostate cancer | 0.910782 |
| small piece | 0.224817 |
| high-energy sound waves | 0.301594 |
| doctors | 0.208769 |
| biopsy | 0.299031 |
| National Cancer Institute | 0.306666 |
|
CLICK HERE |
| 11968 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH-Approved N95 Particulate Filtering Facepiece Respirators - 3M Suppliers List |
This page contains a suppliers list of NIOSH-Approved N95 Particulate Filtering Facepiece Respirators: 3M Suppliers List |
| PDF version | 0.277174 |
| Radiological Health | 0.281023 |
| Drug Administration | 0.283123 |
| convenience | 0.216273 |
| section | 0.213691 |
| particulate | 0.222256 |
| Surgical N95 Respirators | 0.90622 |
| official endorsement | 0.293517 |
| content | 0.224213 |
| products | 0.228686 |
| NIOSH policy | 0.360381 |
| particular manufacturer | 0.283018 |
| oil | 0.21605 |
| statement | 0.224159 |
| clearance | 0.216407 |
| links | 0.213709 |
| NIOSH-approved N95 respirators | 0.599876 |
|
| validation | 0.214603 |
| Food | 0.214367 |
| Model Number/Product Line | 0.345537 |
| types | 0.216157 |
| surgical mask | 0.283434 |
| airborne particles | 0.299128 |
| CDC/NIOSH | 0.226132 |
| web page | 0.28651 |
| index | 0.214776 |
| procedure | 0.213649 |
| Disclaimer | 0.221147 |
| comprehensive table | 0.273763 |
| letter | 0.214813 |
| websites | 0.22437 |
| facepiece respirators | 0.393606 |
| bold text | 0.282301 |
| user instruction | 0.277485 |
|
CLICK HERE |
| 13775 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Safety | Vaccine Safety | CDC |
CDC's Vaccine Safety website. Resources and information about the safety of specific vaccines, vaccine side effects, and vaccine safety research. |
| in-depth information | 0.44021 |
| CDC | 0.376715 |
| possible vaccine | 0.733538 |
| Preteens Learn | 0.484621 |
| United States | 0.450664 |
| Meningococcal | 0.350288 |
| program | 0.344648 |
| supply | 0.322607 |
| research | 0.32196 |
| vaccine safety reports | 0.840146 |
| School | 0.325099 |
| ways | 0.326795 |
| long-standing vaccine safety | 0.905541 |
| Tdap | 0.32493 |
| VAERS | 0.367026 |
|
| conducts studies | 0.44728 |
| vaccine (Gardasil) | 0.99714 |
| Data | 0.322721 |
| history | 0.322526 |
| New website | 0.468816 |
| Reporting | 0.326939 |
| vaccine safety | 0.927075 |
| current U.S. vaccine | 0.842455 |
| Immunization Safety Office | 0.597547 |
| effects | 0.32319 |
| Vaccine Adverse Events | 0.959718 |
| HPV vaccines | 0.686909 |
| health problems | 0.445086 |
| FDA-approved vaccine | 0.734881 |
| online | 0.326741 |
|
CLICK HERE |
| 15751 |
Centers for Disease Control and Prevention |
Html |
en |
Can States Simultaneously Improve Health Outcomes and ReduceHealth Outcome Disparities? |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| mortality gap | 0.538823 |
| disparity gap improvement | 0.496067 |
| combined-race mortality rate | 0.516877 |
| relative gap reduction | 0.448728 |
| Annual overall mortality | 0.493512 |
| black age-adjusted mortality | 0.431542 |
| annual percentage | 0.771389 |
| relative racial disparity | 0.610333 |
| racial gap improvement | 0.403541 |
| absolute racial gap | 0.540488 |
| relative racial mortality | 0.610174 |
| racial mortality gap | 0.527561 |
| combined-race mortality improvement | 0.518494 |
| disparity measure reductions | 0.453752 |
| absolute disparity reduction | 0.46004 |
| age-adjusted mortality | 0.546103 |
| population health disparity | 0.480067 |
| disparity measure | 0.729551 |
| black–white mortality gap | 0.483336 |
| relative black-to-white mortality | 0.473171 |
| relative black-to-white ratio | 0.435983 |
| mortality disparity measures | 0.619895 |
| disparity reduction targets | 0.421625 |
| relative mortality disparity | 0.679905 |
| states | 0.506516 |
|
| relative disparity results | 0.484568 |
| relative disparity measure | 0.702292 |
| mortality absolute gap | 0.494922 |
| disparity reduction rates | 0.472425 |
| combined-race mortality | 0.890185 |
| white age-adjusted mortality | 0.431604 |
| annual percentage changes | 0.442348 |
| racial gap | 0.592221 |
| absolute mortality gap | 0.522069 |
| absolute disparity measure | 0.549506 |
| mean mortality improvement | 0.515709 |
| mortality racial gap | 0.567504 |
| mean combined-race mortality | 0.460548 |
| annual percentage improvement | 0.451602 |
| improvement | 0.607338 |
| annual improvement | 0.4644 |
| health disparity index | 0.445662 |
| absolute gap reduction | 0.42305 |
| disparity reduction | 0.740488 |
| annual percentage change | 0.737382 |
| ratio disparity measure | 0.412848 |
| relative disparity reduction | 0.482033 |
| mortality | 0.944943 |
| relative disparity | 0.822316 |
|
CLICK HERE |